2019
In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review
Rathish D, Agampodi S, Jayasumana C. In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review. Environmental Science And Pollution Research 2019, 26: 29597-29605. PMID: 31446595, DOI: 10.1007/s11356-019-06227-2.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide-1GLP-1 secretionGlucagon-like peptide-1 secretionDipeptidyl peptidase-4 (DPP-4) enzymeRole of atropineVivo studiesPeptide-1 secretionRisk of biasPostprandial glucose homeostasisEx vivo studyPostprandial secretionCholinergic pathwaysAnticholinergic agentsCochrane LibraryHealthy menMuscarinic receptorsGlucose homeostasisPeptide-1Reference listsCompetitive antagonistHuman studiesAnimal studiesPRISMA statementSystematic reviewAtropine
2016
The status of dermatoglyphics as a biomarker of Tel Hashomer camptodactyly syndrome: a review of the literature
Wijerathne BT, Meier RJ, Agampodi SB. The status of dermatoglyphics as a biomarker of Tel Hashomer camptodactyly syndrome: a review of the literature. Journal Of Medical Case Reports 2016, 10: 258. PMID: 27650795, PMCID: PMC5030737, DOI: 10.1186/s13256-016-1048-7.Peer-Reviewed Original ResearchConceptsTel Hashomer camptodactyly syndromeDermatoglyphic featuresCases of patientsAvailable casesMeta-Analyses (PRISMA) statementPreferred Reporting ItemsSystematic literature searchEarly fetal developmentEarly fetal periodClinical featuresCochrane LibraryPalmar creasesRare diseaseIntrauterine effectsTrip DatabaseReporting ItemsFetal developmentGrowth disturbanceFlexion creasesSyndromeSystematic reviewFetal periodFuture patientsPhenotypic biomarkersLiterature search